cbdMD Inc
General ticker "YCBD" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $1.7M
cbdMD Inc does not follow the US Stock Market performance with the rate: -43.6%.
Estimated limits based on current volatility of 9.6%: low 0.32$, high 0.39$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-09-30 to 2025-09-29
- 2023-09-30 to 2024-09-29 estimated range: [0.41$, 1.76$]
- 2024-09-29 to 2025-09-29 estimated range: [0.30$, 1.10$]
Short-term YCBD quotes
Long-term YCBD plot with estimates
Financial data
| YTD | 2023-09-30 | 2024-09-30 |
|---|---|---|
| Operating Revenue | $24.16MM | $19.48MM |
| Operating Expenses | $33.42MM | $22.80MM |
| Operating Income | $-9.27MM | $-3.32MM |
| Non-Operating Income | $-13.67MM | $-0.38MM |
| R&D Expense | $0.17MM | $0.04MM |
| Income(Loss) | $-22.94MM | $-3.70MM |
| Profit(Loss) | $-22.94MM | $-3.70MM |
| Stockholders Equity | $9.03MM | $1,963.42MM |
| Inventory | $4.05MM | $2.37MM |
| Assets | $16.20MM | $10.58MM |
| Operating Cash Flow | $-4.30MM | $-0.35MM |
| Capital expenditure | $0.30MM | $0.29MM |
| Investing Cash Flow | $0.70MM | $-0.29MM |
| Financing Cash Flow | $-1.32MM | $1.30MM |
| Earnings Per Share* | $-13.32 | $-1.93 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.